The purpura treatment market is experiencing substantial growth, driven by heightened awareness of rare blood disorders and advancements in medical technologies. Increased prevalence of autoimmune diseases and rising demand for personalized medicine are significant contributors, prompting a surge in research for innovative therapeutics such as biologics, gene-based therapies, and...